Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

505
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
505
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

319
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
319
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

76
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
76
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

181
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
181

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conduction system pacing in TAVR patients requiring permanent pacemaker implantation.

Heart rhythm·2026
Same author

From photoshop to artificial intelligence. Scientific integrity in the modern era of cardiovascular research: a call for action.

Journal of cardiovascular medicine (Hagerstown, Md.)·2026
Same author

Strategies and Timing of Complete Revascularization in STEMI Patients with Multivessel Coronary Artery Disease.

Journal of clinical medicine·2026
Same author

CT-based radiomics as a non-invasive virtual biopsy for high PD-L1 expression prediction in non-small cell lung cancer.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same author

Antiplatelet Therapy and All-Cause Mortality After Transcatheter Aortic Valve Replacement: The TRITAVI Registry.

JACC. Advances·2026
Same author

Potentially futile outcome after uncomplicated TAVI: Insights from the TRITAVI registry.

American heart journal·2026

Related Experiment Video

Updated: Nov 10, 2025

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

16.9K

CBRA: Cardiac biomarkers release analyzer.

Anna Procopio1, Salvatore De Rosa2, Francesco Montefusco3

  • 1Biomechatronics Lab, Dept. of Experimental and Clinical Medicine, Università degli Studi Magna Græcia, Catanzaro 88100, Italy.

Computer Methods and Programs in Biomedicine
|April 4, 2021
PubMed
Summary

CBRA software aids in personalized medicine by reconstructing cardiac biomarker release curves for ST-Elevation Acute Myocardial Infarction (STEMI) patients. This innovation supports faster diagnosis and objective clinical decision-making.

Keywords:
Acute myocardial infarctionCardiac biomarkersComputer-aided diagnosis

More Related Videos

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

36.9K
Measurement of Myocardial Lactate Production for Diagnosis of Coronary Microvascular Spasm
06:18

Measurement of Myocardial Lactate Production for Diagnosis of Coronary Microvascular Spasm

Published on: September 17, 2021

1.6K

Related Experiment Videos

Last Updated: Nov 10, 2025

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

16.9K
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

36.9K
Measurement of Myocardial Lactate Production for Diagnosis of Coronary Microvascular Spasm
06:18

Measurement of Myocardial Lactate Production for Diagnosis of Coronary Microvascular Spasm

Published on: September 17, 2021

1.6K

Area of Science:

  • Biomedical Engineering
  • Computational Biology
  • Clinical Informatics

Background:

  • Advanced medical technologies necessitate collaboration between clinical and engineering fields.
  • Software applications serve as crucial bridges, offering analytical capabilities for complex medical data.
  • Personalized medicine requires innovative tools for patient triage, diagnosis, and prognosis.

Purpose of the Study:

  • Introduce CBRA, an innovative software platform designed for personalized medicine.
  • Simplify and accelerate patient triage and support clinical diagnostic and prognostic phases.
  • Facilitate the interaction between clinical practice and engineering innovation.

Main Methods:

  • Utilize a model-based identification algorithm for reconstructing cardiac biomarker release curves.
  • Employ identification and parametric optimization techniques for individual patient analysis.
  • Develop a user-friendly interface with a dedicated database for managing patient data.

Main Results:

  • Demonstrate CBRA's application in managing cardiac biomarker time-series data.
  • Extract quantitative clinical features from reconstructed curves, such as peak biomarker concentrations and timing.
  • Identify key indicators like time to symptom onset for acute myocardial infarction (AMI) patients.

Conclusions:

  • CBRA simplifies the use of modeling and parametric identification for release curve reconstruction.
  • The platform supports clinical decisions by extracting high-value information beyond visual analysis.
  • CBRA aids in determining the stage of AMI, enabling optimized therapeutic strategies.